A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
Conditions: Non-erosive Reflux Disease; Erosive Esophagitis Intervention: Drug: BLI5100 Sponsor: Braintree Laboratories Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Research | Study